Literature DB >> 26725067

Refractory Autoimmune Hepatitis: Beyond Standard Therapy.

Jonah N Rubin1, Helen S Te2.   

Abstract

Autoimmune hepatitis (AIH) can be difficult to control, particularly in some African-Americans. When standard therapy of prednisone and azathioprine is ineffective or poorly tolerated, alternative therapies are resorted to. We report two patients with AIH who were refractory to or intolerant of standard therapy. They initially responded to a combination of tacrolimus and MMF, but eventually developed acute flares of the disease that had to be managed with sirolimus, and in one case, rituximab, to achieve remission.

Entities:  

Keywords:  Rapamycin; Refractory autoimmune hepatitis; Rituximab; Sirolimus; Tacrolimus

Mesh:

Substances:

Year:  2016        PMID: 26725067     DOI: 10.1007/s10620-015-4022-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells.

Authors:  E G Kamburova; H J P M Koenen; L Boon; L B Hilbrands; I Joosten
Journal:  Am J Transplant       Date:  2011-11-09       Impact factor: 8.086

2.  Diagnosis and management of autoimmune hepatitis.

Authors:  Michael P Manns; Albert J Czaja; James D Gorham; Edward L Krawitt; Giorgina Mieli-Vergani; Diego Vergani; John M Vierling
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

3.  Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory or intolerant to conventional therapy.

Authors:  Kaveh Sharzehi; Mary Ann Huang; Ian R Schreibman; Kimberly A Brown
Journal:  Can J Gastroenterol       Date:  2010-10       Impact factor: 3.522

Review 4.  Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

Authors:  Anna L Taylor; Christopher J E Watson; J Andrew Bradley
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

5.  Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience.

Authors:  M M Tannous; J Cheng; K Muniyappa; I Farooq; A Bharara; M Kappus; V Luketic; R T Stravtiz; M Fuchs; P Puri; A Sanyal; R Sterling
Journal:  Aliment Pharmacol Ther       Date:  2011-08       Impact factor: 8.171

6.  Role of mycophenolate mofetil for the treatment of autoimmune hepatitis-an observational study.

Authors:  Dinesh Jothimani; Mathew E Cramp; Tim J S Cross
Journal:  J Clin Exp Hepatol       Date:  2014-06-24

7.  mTOR Ser-2481 autophosphorylation monitors mTORC-specific catalytic activity and clarifies rapamycin mechanism of action.

Authors:  Ghada A Soliman; Hugo A Acosta-Jaquez; Elaine A Dunlop; Bilgen Ekim; Nicole E Maj; Andrew R Tee; Diane C Fingar
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature.

Authors:  Edgardo S Santos; Leopoldo R Arosemena; Luis E Raez; Christopher O'Brien; Arie Regev
Journal:  Liver Int       Date:  2006-06       Impact factor: 5.828

9.  Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help.

Authors:  S Heidt; D L Roelen; C Eijsink; M Eikmans; C van Kooten; F H J Claas; A Mulder
Journal:  Clin Exp Immunol       Date:  2009-11-18       Impact factor: 4.330

Review 10.  Autoimmune hepatitis in diverse ethnic populations and geographical regions.

Authors:  Albert J Czaja
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-05       Impact factor: 3.869

View more
  6 in total

Review 1.  The Contribution of B Cells in Autoimmune Liver Diseases.

Authors:  Sarah A Taylor; David N Assis; Cara L Mack
Journal:  Semin Liver Dis       Date:  2019-06-21       Impact factor: 6.115

Review 2.  Risk and Surveillance of Cancers in Primary Biliary Tract Disease.

Authors:  Valery Hrad; Yoftahe Abebe; Syed Haris Ali; Jared Velgersdyk; Mohammed Al Hallak; Mohamad Imam
Journal:  Gastroenterol Res Pract       Date:  2016-06-19       Impact factor: 2.260

Review 3.  Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis.

Authors:  Marco Sciveres; Silvia Nastasio; Giuseppe Maggiore
Journal:  Front Pediatr       Date:  2019-09-20       Impact factor: 3.418

Review 4.  Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.

Authors:  Benedetta Terziroli Beretta-Piccoli; Giorgina Mieli-Vergani; Diego Vergani
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

5.  Efficacy and safety of chloroquine plus prednisone for the treatment of autoimmune hepatitis in a randomized trial.

Authors:  Lydia T de Moraes Falcão; Debora R B Terrabuio; Marcio A Diniz; Andreia da Silva Evangelista; Fabricio G Souza; Eduardo L R Cancado
Journal:  JGH Open       Date:  2019-09-10

Review 6.  Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies.

Authors:  Elisabeth Sucher; Robert Sucher; Tanja Gradistanac; Gerald Brandacher; Stefan Schneeberger; Thomas Berg
Journal:  J Immunol Res       Date:  2019-11-25       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.